These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9221760)

  • 41. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.
    Jäger A; Dardalhon V; Sobel RA; Bettelli E; Kuchroo VK
    J Immunol; 2009 Dec; 183(11):7169-77. PubMed ID: 19890056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The complexicity of cytokine treatment in ongoing EAE induced with MBP peptide 68-86 in Lewis rats.
    Xu LY; Ishikawa M; Huang YM; Levi M; van der Meide PH; Wahren B; Link H; Xiao BG
    Clin Immunol; 2000 Apr; 95(1 Pt 1):70-8. PubMed ID: 10794434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acetylcholine regulates the development of experimental autoimmune encephalomyelitis via the CD4+ cells proliferation and differentiation.
    Zhou L; Lin X; Ma X; Liu Y; Ma L; Chen Z; Chen H; Si L; Chen X
    Int J Neurosci; 2020 Aug; 130(8):788-803. PubMed ID: 31906749
    [No Abstract]   [Full Text] [Related]  

  • 44. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells.
    Khoruts A; Miller SD; Jenkins MK
    J Immunol; 1995 Nov; 155(10):5011-7. PubMed ID: 7594508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.
    Kuchroo VK; Das MP; Brown JA; Ranger AM; Zamvil SS; Sobel RA; Weiner HL; Nabavi N; Glimcher LH
    Cell; 1995 Mar; 80(5):707-18. PubMed ID: 7534215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gammadelta T cells enhance the expression of experimental autoimmune encephalomyelitis by promoting antigen presentation and IL-12 production.
    Odyniec A; Szczepanik M; Mycko MP; Stasiolek M; Raine CS; Selmaj KW
    J Immunol; 2004 Jul; 173(1):682-94. PubMed ID: 15210832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.
    Okuda Y; Sakoda S; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
    J Neuroimmunol; 1999 Nov; 101(2):188-96. PubMed ID: 10580801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effects of catalpol and rhein in murine experimental autoimmune encephalomyelitis via regulation of T helper (Th) 1, Th2, Th17, and regulatory T cell responses.
    Wei M; Yang T; Li Q; Zhou D; Du Z; Fan Y
    J Tradit Chin Med; 2019 Dec; 39(6):809-817. PubMed ID: 32186151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphokine mRNA expression in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis is associated with a host recruited CD45R hi/CD4+ population during recovery.
    Weinberg AD; Wyrick G; Celnik B; Vainiene M; Bakke A; Offner H; Vandenbark AA
    J Neuroimmunol; 1993 Oct; 48(1):105-17. PubMed ID: 7693749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue.
    Wolf SA; Gimsa U; Bechmann I; Nitsch R
    Glia; 2001 Dec; 36(3):414-20. PubMed ID: 11746777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
    Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of helper T cell subsets in autoimmune diseases.
    Lafaille JJ
    Cytokine Growth Factor Rev; 1998 Jun; 9(2):139-51. PubMed ID: 9754708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
    Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
    Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit.
    Costa GL; Sandora MR; Nakajima A; Nguyen EV; Taylor-Edwards C; Slavin AJ; Contag CH; Fathman CG; Benson JM
    J Immunol; 2001 Aug; 167(4):2379-87. PubMed ID: 11490028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental allergic encephalomyelitis in susceptible and resistant strains of mice after adoptive transfer of T cells activated by antibodies to the T cell receptor complex.
    Zhao ML; Xia JQ; Fritz RB
    J Neuroimmunol; 1992 Sep; 40(1):31-9. PubMed ID: 1381381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis.
    Faunce DE; Terajewicz A; Stein-Streilein J
    J Immunol; 2004 Feb; 172(4):1991-5. PubMed ID: 14764660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.